SYMPHOGEN
Symphogen is the leader in developing recombinant polyclonal antibodies (rpAb), a new class of biopharmaceuticals for the treatment or prophylaxis of serious human diseases.
SYMPHOGEN
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2000-01-01
Address:
Lyngby, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.symphogen.com
Total Employee:
101+
Status:
Active
Contact:
45 45 26 50 50
Email Addresses:
[email protected]
Total Funding:
375.22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics WordPress Google Universal Analytics Domain Not Resolving Sitelinks Search Box Euro
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Current Advisors List
Current Employees Featured
Founder
Investors List
PKA
PKA investment in Debt Financing - Symphogen
Novo Holdings
Novo Holdings investment in Debt Financing - Symphogen
Novo Holdings
Novo Holdings investment in Private Equity Round - Symphogen
Danica Pension
Danica Pension investment in Private Equity Round - Symphogen
PKA
PKA investment in Private Equity Round - Symphogen
Novo Holdings
Novo Holdings investment in Venture Round - Symphogen
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Venture Round - Symphogen
PKA
PKA investment in Venture Round - Symphogen
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Venture Round - Symphogen
GenenFUND
GenenFUND investment in Private Equity Round - Symphogen
Official Site Inspections
http://www.symphogen.com Semrush global rank: 8.93 M Semrush visits lastest month: 229
- Host name: linux1.curanet.dk
- IP address: 94.231.106.219
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
